Antioxidant shows promise in sepsis battle
NCT ID NCT06661993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a supplement called alpha-lipoic acid could help critically ill patients with sepsis. Eighty adults with sepsis were randomly assigned to receive either the supplement or a placebo daily for seven days. Researchers measured organ function, inflammation, and recovery time to see if the supplement improved outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Damanhūr, Elbehairah, 31527, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?